John E. Alessi
- +1 617 728 7186
- john.alessi@dechert.com
- vCard
-
Boston OfficeOne International Place, 40th Floor, 100 Oliver Street, Boston, MA, United States of America 02110-2605
John E. Alessi focuses his practice on mergers and acquisitions. Mr. Alessi has significant experience representing public and private companies in matters relating to mergers and acquisitions, restructuring, and capital markets. He regularly represents clients from the life science and technology sectors, across a range of jurisdictions.
Prior to joining Dechert, Mr. Alessi was an attorney in the Boston office of an international law firm.
Life Sciences and Technology M&A
- Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, in its sale to Stryker Corporation, one of the world’s leading medical technology companies, by way of a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006.
- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) in connection with a proposed merger with clinical-stage biotechnology company EIP Pharma Inc. (to be renamed “CervoMed”).
- Zyla Life Sciences in its merger with Assertio Therapeutics, Inc.
- Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain, in its debt restructuring and pending acquisition of four FDA-approved, non-narcotic pain products from Iroko Pharmaceuticals, Inc.
- IntraLinks Holdings, Inc., in its auction and sale process resulting in a sale to Synchronoss Technologies, Inc., valued at approximately US$821 million.
- Novell, Inc., in responding to an unsolicited acquisition offer in a process that resulted in an auction and sale of the company in a concurrent patent sale and merger valued at US$2.2 billion.
- Gilead Sciences, Inc., in its acquisition of clinical program asset from a German private biopharmaceutical company in a transaction worth up to US$470 million.
- Broadcom Corporation in its US$165 million acquisition of a modem-related division of Japanese semiconductor manufacturer Renesas Electronics.
- Vocus, Inc., in its auction and sale process resulting in a sale to GTCR valued at US$450 million.
- Rhythmia Medical, Inc., in its US$265 million sale to Boston Scientific Corporation.
- Broadcom Corporation in its US$3.7 billion acquisition of NetLogic Microsystems Inc.
Private Equity and Financial Services/Asset Management M&A
- EnTrust Global on its acquisition from Franklin Templeton of the 65% interest that Legg Mason, Inc. holds in EnTrust Global.
- StoneCastle Partners in the sale of its subsidiary, StoneCastle Cash Insured Sweep, LLC (d/b/a interLINK), to Webster Financial Corporation’s principle bank subsidiary, Webster Bank, N.A.
- StoneCastle Asset Management and its parent StoneCastle Partners LLC on its sale of StoneCastle Asset Management’s Bank Investment Platform to ArrowMark Partners.
- Further Global Capital Management on its acquisition of U.S.-headquartered Payment Alliance International (PAI), the nation’s largest privately- held ATM provider.
Spin-Offs and Capital Market Transactions
- Biogen, Inc., in its spin-off of Bioverativ Inc., with an initial market capitalization of approximately US$4.8 billion.
- Citrix Systems, Inc., in its spin-off and sale of its “GoTo” software business to LogMeIn, Inc., valued at approximately US$1.8 billion.
- The RMR Group, Inc., in its public offering by way of a distribution through its public shareholders.
Includes matters handled at Dechert or prior to joining the firm.
Services
Industries
-
- Duke University, B.A., 1996
- Columbia Law School, J.D., 2003
-
- Massachusetts
- New York